1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. BRAINSTORM CELL THERAPEUTICS, INC.
Brainstorm Cell Therapeutics, Inc. XNAS: BCLI

Watchlist

Portfolio

Alert

Share


Insider Trading disclosures for Brainstorm Cell Therapeutics, Inc.

The latest disclosure was made by Irit Arbel in Brainstorm Cell Therapeutics, Inc. where a trade of 30,666 Common Stock done was reported to US exchanges on Jan. 1, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Irit Arbel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 30,666 41,054 (0%) 0% 0 Common Stock
Hartoun Hartounian EVP, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 50,000 52,000 (0%) 0% 0 Common Stock
Jacob A. Frenkel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 40,000 43,777 (0%) 0% 0 Common Stock
Chaim Lebovits President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 120,000 200,960 (0%) 0% 0 Common Stock
Uri Yablonka Director, EVP & Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 40,000 48,464 (0%) 0% 0 Common Stock
Uri Yablonka Director, EVP & Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 20,000 68,464 (0%) 0% 0 Common Stock
Alla Patlis See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 40,000 44,349 (0%) 0% 0 Common Stock
Anthony J. Polverino Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 24,000 25,730 (0%) 0% 0 Common Stock
Stacy R. Lindborg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 20,000 48,229 (0%) 0% 0 Common Stock
Menghisteab Bairu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 24,000 24,000 (0%) 0% 0 Common Stock
Nir Naor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 30,666 31,465 (0%) 0% 0 Common Stock
Ibrahim B. Dagher Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 50,000 66,849 (0%) 0% 0 Common Stock
Chaim Lebovits President & CEO Purchase of securities on an exchange or from another person at price $ 3.43 per share. 30 Sep 2024 1,836 80,960 (0%) 0% 3.4 6,292 Common Stock
Chaim Lebovits President & CEO Purchase of securities on an exchange or from another person at price $ 0.23 per share. 30 Sep 2024 22,000 1,186,865 (4%) 0% 0.2 5,016 Common Stock
Ibrahim B. Dagher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.35 per share. 19 Jul 2024 63,000 0 (0%) 0% 0.4 22,069 Common Stock
Haro Hartounian EVP, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2024 60,000 60,000 - - Stock Option (Right to Buy)
Haro Hartounian EVP, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2024 30,000 30,000 (0%) 0% 0 Common Stock
Chaim Lebovits President & CEO Grant, award, or other acquisition of securities at price $ 0.52 per share. 28 May 2024 15,000 1,164,865 (4%) 0% 0.5 7,775 Common Stock
Chaim Lebovits President & CEO Purchase of securities on an exchange or from another person at price $ 0.52 per share. 28 May 2024 15,000 1,164,865 (4%) 0% 0.5 7,775 Common Stock
Chaim Lebovits President & CEO Grant, award, or other acquisition of securities at price $ 0.58 per share. 21 May 2024 25,000 1,124,865 (4%) 0% 0.6 14,475 Common Stock
Chaim Lebovits President & CEO Grant, award, or other acquisition of securities at price $ 0.64 per share. 21 May 2024 25,000 1,149,865 (4%) 0% 0.6 16,000 Common Stock
Chaim Lebovits President & CEO Purchase of securities on an exchange or from another person at price $ 0.58 per share. 21 May 2024 25,000 1,124,865 (4%) 0% 0.6 14,475 Common Stock
Chaim Lebovits President & CEO Purchase of securities on an exchange or from another person at price $ 0.64 per share. 21 May 2024 25,000 1,149,865 (4%) 0% 0.6 16,000 Common Stock
Chaim Lebovits President & CEO Grant, award, or other acquisition of securities at price $ 0.47 per share. 10 May 2024 10,000 1,089,865 (4%) 0% 0.5 4,665 Common Stock
Chaim Lebovits President & CEO Grant, award, or other acquisition of securities at price $ 0.46 per share. 10 May 2024 20,000 1,079,865 (4%) 0% 0.5 9,300 Common Stock
Chaim Lebovits President & CEO Grant, award, or other acquisition of securities at price $ 0.49 per share. 10 May 2024 10,000 1,099,865 (4%) 0% 0.5 4,900 Common Stock
Chaim Lebovits President & CEO Purchase of securities on an exchange or from another person at price $ 0.46 per share. 10 May 2024 20,000 1,079,865 (4%) 0% 0.5 9,300 Common Stock
Chaim Lebovits President & CEO Purchase of securities on an exchange or from another person at price $ 0.47 per share. 10 May 2024 10,000 1,089,865 (4%) 0% 0.5 4,665 Common Stock
Chaim Lebovits President & CEO Purchase of securities on an exchange or from another person at price $ 0.49 per share. 10 May 2024 10,000 1,099,865 (4%) 0% 0.5 4,900 Common Stock
Chaim Lebovits President & CEO Grant, award, or other acquisition of securities at price $ 0.37 per share. 07 May 2024 66,300 1,059,865 (4%) 0% 0.4 24,816 Common Stock
Chaim Lebovits President & CEO Purchase of securities on an exchange or from another person at price $ 0.37 per share. 07 May 2024 66,300 1,059,865 (4%) 0% 0.4 24,816 Common Stock
Chaim Lebovits President & CEO Grant, award, or other acquisition of securities at price $ 0.38 per share. 06 May 2024 135,000 993,565 (3%) 0% 0.4 50,666 Common Stock
Chaim Lebovits President & CEO Purchase of securities on an exchange or from another person at price $ 0.38 per share. 06 May 2024 135,000 993,565 (3%) 0% 0.4 50,666 Common Stock
Chaim Lebovits President & CEO Grant, award, or other acquisition of securities at price $ 0.52 per share. 19 Apr 2024 15,000 858,565 (3%) 0% 0.5 7,799 Common Stock
Chaim Lebovits President & CEO Purchase of securities on an exchange or from another person at price $ 0.52 per share. 19 Apr 2024 15,000 858,565 (3%) 0% 0.5 7,799 Common Stock
Chaim Lebovits President & CEO Grant, award, or other acquisition of securities at price $ 0.53 per share. 17 Apr 2024 115,072 843,565 (3%) 0% 0.5 60,470 Common Stock
Chaim Lebovits President & CEO Grant, award, or other acquisition of securities at price $ 0.55 per share. 17 Apr 2024 130,000 728,493 (2%) 0% 0.5 70,941 Common Stock
Chaim Lebovits President & CEO Purchase of securities on an exchange or from another person at price $ 0.55 per share. 17 Apr 2024 130,000 728,493 (2%) 0% 0.5 70,941 Common Stock
Chaim Lebovits President & CEO Purchase of securities on an exchange or from another person at price $ 0.53 per share. 17 Apr 2024 115,072 843,565 (3%) 0% 0.5 60,470 Common Stock
Chaim Lebovits President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2024 305,198 598,493 (2%) 1% 0 Common Stock
Uri Yablonka Director, EVP & Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2024 109,426 126,969 (0%) 0% 0 Common Stock
Alla Patlis See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2024 65,246 65,246 (0%) 0% 0 Common Stock
Stacy R. Lindborg Co-Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2024 241,935 423,435 (1%) 0% 0 Common Stock
Chaim Lebovits President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2023 31,185 293,295 (1%) 0% 0 Common Stock
Stacy R. Lindborg Co-Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2023 35,000 170,000 (0%) 0% 0 Common Stock
Nir Naor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2023 11,999 11,999 (0%) 0% 0 Common Stock
Kirk Taylor Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2023 80,000 80,000 - - Stock Option (right to buy)
Kirk Taylor Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2023 35,000 35,000 (0%) 0% 0 Common Stock
Chaim Lebovits President & Co-CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Apr 2023 75,000 262,110 (0%) 0% 0 Common Stock
Stacy R. Lindborg Co-Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Apr 2023 75,000 135,000 (0%) 0% 0 Common Stock
Stacy R. Lindborg Co-Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Dec 2022 35,000 60,000 (0%) 0% 0 Common Stock
Chaim Lebovits Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2022 31,185 187,110 (0%) 0% 0 Common Stock
Jacob A. Frenkel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Apr 2022 50,000 50,000 - - Stock Option (right to buy)
Ralph Kern COO and Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2022 35,885 223,310 (0%) 0% 0 Common Stock
Anthony J. Polverino Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 3,882 25,960 (0%) 0% 0 Common Stock
Preetam Shah EVP, CFO and Treasurer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.64 per share. 30 Dec 2020 25,000 11,600 (0%) 0% 4.6 116,000 Common Stock
Stacy Lindborg EVP, Head Global Clin Research Purchase of securities on an exchange or from another person at price $ 0.00 per share. 17 Nov 2020 200 200 - - Call Option (right to buy)
Anthony Waclawski See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Sep 2020 35,000 35,000 (0%) 0% 0 Common Stock
Anthony Waclawski See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Sep 2020 80,000 80,000 - - Stock Option (Right to Buy)
Chaim Lebovits Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jul 2020 31,185 124,740 (0%) 0% 0 Common Stock
David Setboun EVP and COO Purchase of securities on an exchange or from another person at price $ 12.95 per share. 16 Jul 2020 5,000 55,000 (0%) 0% 12.9 64,740 Common Stock
Sankesh Abbhi Director Purchase of securities on an exchange or from another person at price $ 12.99 per share. 15 Jul 2020 46,779 2,164,530 (8%) 0% 13.0 607,659 Common Stock
Uri Yablonka Director, EVP & Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2020 10,000 17,543 (0%) 0% 0 Common Stock
Stacy Lindborg EVP, Head Global Clin Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2020 100,000 100,000 - - Stock Option (right to buy)
Stacy Lindborg EVP, Head Global Clin Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2020 25,000 25,000 (0%) 0% 0 Common Stock
David Setboun EVP and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2020 50,000 50,000 (0%) 0% 0 Common Stock
Jacob A. Frenkel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Apr 2020 50,000 50,000 - - Stock Option (right to buy)
Sankesh Abbhi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Apr 2020 4,657 4,657 (0%) 0% 0 Common Stock
Ralph Kern COO and Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2020 80,000 80,000 - - Stock Option (right to buy)
Ralph Kern COO and Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2020 35,885 151,540 (0%) 0% 0 Common Stock
Arturo O. Araya Chief Commercial Officer Purchase of securities on an exchange or from another person at price $ 3.90 per share. 24 Dec 2019 3,000 8,608 (0%) 0% 3.9 11,700 Common Stock
Ralph Kern COO and Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 3.88 per share. 24 Dec 2019 3,000 115,655 (0%) 0% 3.9 11,640 Common Stock
Preetam Shah EVP, CFO and Treasurer Purchase of securities on an exchange or from another person at price $ 3.96 per share. 24 Dec 2019 11,600 36,600 (0%) 0% 4.0 45,929 Common Stock
Irit Arbel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2019 25,333 25,333 - - Stock Option (right to buy)
Malcolm S. Taub Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2019 12,000 53,332 (0%) 0% 0 Common Stock
June S. Almenoff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2019 2,000 2,000 (0%) 0% 0 Common Stock
Uri Yablonka Director, EVP and Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2019 13,333 13,333 - - Stock Option (right to buy)
Anthony J. Polverino Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2019 3,071 15,862 (0%) 0% 0 Common Stock
Anthony J. Polverino Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2019 2,000 12,791 (0%) 0% 0 Common Stock
Preetam Shah EVP, CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Sep 2019 100,000 100,000 - - Stock Option (right to buy)
Preetam Shah EVP, CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Sep 2019 25,000 25,000 (0%) 0% 0 Common Stock
Preetam Shah EVP, CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Sep 2019 100,000 100,000 - - Stock Option (right to buy)
Irit Arbel Director Sale of securities on an exchange or to another person at price $ 3.67 per share. 28 Aug 2019 13,332 155,833 (0%) 0% 3.7 48,891 Common Stock
Irit Arbel Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Aug 2019 6,666 0 - - Stock Option (right to buy)
Irit Arbel Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Aug 2019 6,666 0 - - Stock Option (right to buy)
Irit Arbel Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. 28 Aug 2019 6,666 169,165 (0%) 0% 2.3 14,999 Common Stock
Irit Arbel Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. 28 Aug 2019 6,666 162,499 (0%) 0% 2.3 14,999 Common Stock
Chaim Lebovits See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jul 2019 31,185 2,166,155 (8%) 0% 0 Common Stock
Ralph Kern COO and Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2019 35,885 112,655 (0%) 0% 0 Common Stock
Anthony J. Polverino Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2019 3,501 10,791 (0%) 0% 0 Common Stock
June S. Almenoff Director Purchase of securities on an exchange or from another person at price $ 3.39 per share. 04 Jan 2019 1,475 7,175 (0%) 0% 3.4 5,000 Common Stock
Chen Schor None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Nov 2018 2,000 125,558 (0%) 0% 0 Common Stock
Irit Arbel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Nov 2018 25,333 25,333 - - Stock Option (right to buy)
Malcolm S. Taub None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Nov 2018 12,000 41,332 (0%) 0% 0 Common Stock
Uri Yablonka Director, EVP and Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Nov 2018 13,333 13,333 - - Stock Option (right to buy)
Anthony J. Polverino None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Nov 2018 2,000 5,623 (0%) 0% 0 Common Stock
Anthony J. Polverino None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Nov 2018 1,667 7,290 (0%) 0% 0 Common Stock
Chen Schor None Gift of securities by or to the insider at price $ 0.00 per share. 24 Oct 2018 121,558 4,000 (0%) 0% 0 Common Stock
Chen Schor None Gift of securities by or to the insider at price $ 0.00 per share. 24 Oct 2018 121,558 121,558 (0%) 0% 0 Common Stock
Arturo O. Araya Director, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Aug 2018 200,000 200,000 - - Stock Option (right to buy)
Arturo O. Araya Director, Chief Commercial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 28 Aug 2018 2,805 5,608 (0%) 0% 0 Common Stock
Chaim Lebovits See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jul 2018 31,185 2,134,970 (10%) 0% 0 Common Stock
Arturo O. Araya None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2018 1,249 8,413 (0%) 0% 0 Common Stock
June S. Almenoff None Purchase of securities on an exchange or from another person at price $ 3.50 per share. 15 Mar 2018 5,700 5,700 (0%) 0% 3.5 19,950 Common Stock
Ralph Kern COO and Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 3.60 per share. 15 Mar 2018 5,000 40,885 (0%) 0% 3.6 17,997 Common Stock
Ralph Kern COO and Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2018 35,885 76,770 (0%) 0% 0 Common Stock
Arturo O. Araya None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2018 4,152 7,164 (0%) 0% 0 Common Stock
Anthony J. Polverino None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2018 3,623 3,623 (0%) 0% 0 Common Stock
Eyal Rubin CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Nov 2017 25,000 25,000 (0%) 0% 0 Common Stock
Eyal Rubin CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Nov 2017 93,686 93,686 - - Stock Option (right to buy)
Chen Schor None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Nov 2017 2,000 123,558 (0%) 0% 0 Common Stock
Irit Arbel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Nov 2017 25,333 25,333 - - Stock Option (right to buy)
Robert G.L. Shorr None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Nov 2017 8,666 45,731 (0%) 0% 0 Common Stock
Malcolm S. Taub None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Nov 2017 12,000 29,332 (0%) 0% 0 Common Stock
Uri Yablonka Director, EVP and Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Nov 2017 13,333 13,333 - - Stock Option (right to buy)
Irit Arbel None Purchase of securities on an exchange or from another person at price $ 4.26 per share. 31 Aug 2017 2,500 155,833 (0%) 0% 4.3 10,650 Common Stock
Uri Yablonka Director, EVP & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 3.98 per share. 23 Aug 2017 2,000 7,543 (0%) 0% 4.0 7,960 Common Stock
Chaim Lebovits See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jul 2017 41,580 41,580 - - Stock Option (right to buy)
Chaim Lebovits See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jul 2017 31,185 2,103,785 (11%) 0% 0 Common Stock
Irit Arbel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2017 12,000 12,000 - - Stock Option (right to buy)
Uri Yablonka Director, EVP & Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2017 5,543 5,543 (0%) 0% 0 Common Stock
Ralph Kern COO and Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2017 35,885 35,885 (0%) 0% 0 Common Stock
Ralph Kern COO and Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2017 47,847 47,847 - - Stock Option (right to buy)
Irit Arbel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2017 6,667 6,667 - - Stock Option (right to buy)
Arturo O. Araya None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2017 3,012 3,012 (0%) 0% 0 Common Stock
Robert G.L. Shorr None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2016 8,666 37,065 - - Common Stock
Irit Arbel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2016 25,333 25,333 - - Stock Option (right to buy)
Malcolm S. Taub None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2016 8,666 17,332 - - Common Stock
Alon Pinkas None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2016 15,333 15,333 - - Stock Option (right to buy)
Mordechai Friedman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2016 16,666 16,666 - - Stock Option (right to buy)
Uri Yablonka Director, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2016 13,333 13,333 - - Stock Option (right to buy)
Robert G.L. Shorr None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Dec 2015 10,800 28,399 - - Common Stock
Malcolm S. Taub None Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Dec 2015 11,263 8,666 - - Common Stock
Malcolm S. Taub None Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Dec 2015 30,479 19,929 - - Common Stock
Mordechai Friedman None Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Dec 2015 5,000 0 - - Common Stock
Mordechai Friedman None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2015 5,000 5,000 - - Common Stock
Mordechai Friedman None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2015 5,000 11,666 - - Stock Option (right to buy)
Robert G.L. Shorr None Sale of securities on an exchange or to another person at price $ 0.00 per share. 10 Dec 2015 5,300 39,199 - - Common Stock
Robert G.L. Shorr None Sale of securities on an exchange or to another person at price $ 0.00 per share. 10 Dec 2015 5,500 44,499 - - Common Stock
Malcolm S. Taub None Sale of securities on an exchange or to another person at price $ 0.00 per share. 10 Dec 2015 980 50,408 - - Common Stock
Malcolm S. Taub None Sale of securities on an exchange or to another person at price $ 0.00 per share. 10 Dec 2015 12,500 51,388 - - Common Stock
Yoram Bibring Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Dec 2015 82,500 82,500 - - Stock Option (right to buy)
Chaim Lebovits See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Sep 2015 369,619 369,619 - - Stock Option (right to buy)
Robert G.L. Shorr None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2015 8,666 49,999 - - Common Stock
Irit Arbel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2015 25,333 25,333 - - Stock Option (right to buy)
Malcolm S. Taub None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2015 8,666 50,554 - - Common Stock
Alon Pinkas None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2015 15,333 15,333 - - Stock Option (right to buy)
Mordechai Friedman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2015 16,666 16,666 - - Stock Option (right to buy)
Uri Yablonka Director, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2015 13,333 13,333 - - Stock Option (right to buy)
Yoram Bibring Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 Aug 2015 8,500 50,000 - - Common Stock
Yoram Bibring Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 17 Aug 2015 41,500 41,500 - - Common Stock
Yoram Bibring Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2015 165,000 165,000 - - Stock Option (right to buy)
Irit Arbel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2015 6,667 6,667 - - Stock Option (right to buy)
Chen Schor None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2015 60,000 121,558 - - Common Stock
Anthony Fiorino Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Oct 2014 200 2,200 - - Common Stock
Anthony Fiorino Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Oct 2014 300 2,500 - - Common Stock
Anthony Fiorino Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 18 Sep 2014 800 2,000 - - Common Stock
Anthony Fiorino Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 12 Sep 2014 2,500 2,500 - - Common Stock
Anthony Fiorino Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 12 Sep 2014 7,500 10,000 - - Common Stock
Anthony Fiorino Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 12 Sep 2014 5,000 15,000 - - Common Stock
Anthony Fiorino Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 12 Sep 2014 3,000 18,000 - - Common Stock
Robert G.L. Shorr None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2014 130,000 620,000 - - Common Stock
Irit Arbel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2014 380,000 380,000 - - Stock Option (right to buy)
Malcolm S. Taub None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2014 130,000 628,333 - - Common Stock
Alon Pinkas None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2014 230,000 230,000 - - Stock Option (right to buy)
Mordechai Friedman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2014 250,000 250,000 - - Stock Option (right to buy)
Uri Yablonka Director, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2014 200,000 200,000 - - Stock Option (right to buy)
Anthony Fiorino Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2014 5,700,000 5,700,000 - - Stock Option (right to buy)
Uri Yablonka Director, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2014 500,000 500,000 - - Stock Option (right to buy)
Abraham Israeli None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Apr 2014 166,666 166,666 - - Stock Option (right to buy)
Abraham Israeli None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Apr 2014 133,334 133,334 - - Stock Option (right to buy)
Liat Sossover Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2013 100,000 100,000 - - Stock Option (right to buy)
Robert G.L. Shorr None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2013 130,000 490,000 - - Common Stock
Irit Arbel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2013 180,000 180,000 - - Stock Option (right to buy)
Malcolm S. Taub None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2013 130,000 498,333 - - Common Stock
Alon Pinkas None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2013 130,000 130,000 - - Stock Option (right to buy)
Mordechai Friedman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2013 150,000 150,000 - - Stock Option (right to buy)
Abraham Israeli None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Apr 2013 166,666 166,666 - - Stock Option (right to buy)
Robert G.L. Shorr None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2012 130,000 360,000 - - Common Stock
Irit Arbel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2012 180,000 180,000 - - Stock Option (right to buy)
Malcolm S. Taub None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2012 130,000 368,333 - - Common Stock
Liat Sossover Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2012 60,000 60,000 - - Stock Option (right to buy)
Alon Pinkas None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2012 130,000 130,000 - - Stock Option (right to buy)
Adrian Harel Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2012 70,000 70,000 - - Stock Option (right to buy)
Mordechai Friedman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2012 150,000 150,000 - - Stock Option (right to buy)
Abraham Israeli None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Apr 2012 166,666 166,666 - - Stock Option (right to buy)
Robert G.L. Shorr None Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Dec 2011 98,333 230,000 - - Common Stock
Robert G.L. Shorr None Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Nov 2011 10,000 328,333 - - Common Stock
Chen Schor None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2011 923,374 923,374 - - Common Stock
Robert G.L. Shorr None Sale of securities on an exchange or to another person at price $ 0.00 per share. 04 Oct 2011 105,000 433,333 - - Common Stock
Robert G.L. Shorr None Sale of securities on an exchange or to another person at price $ 0.00 per share. 04 Oct 2011 95,000 338,333 - - Common Stock
Chen Schor None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Aug 2011 923,374 923,374 - - Common Stock
Adrian Harel Acting Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2011 70,000 70,000 - - Stock Option (right to buy)
Robert G.L. Shorr None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2011 108,333 408,333 - - Common Stock
Robert G.L. Shorr None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2011 130,000 538,333 - - Common Stock
Irit Arbel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2011 108,333 108,333 - - Stock Option (right to buy)
Irit Arbel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2011 180,000 180,000 - - Stock Option (right to buy)
Alon Pinkas None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2011 50,000 50,000 - - Stock Option (right to buy)
Alon Pinkas None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2011 130,000 130,000 - - Stock Option (right to buy)
Adrian Harel Acting Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2011 450,000 450,000 - - Stock Option (right to buy)
Mordechai Friedman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2011 16,667 16,667 - - Stock Option (right to buy)
Mordechai Friedman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2011 150,000 150,000 - - Stock Option (right to buy)
Malcolm S. Taub None Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Jun 2011 33,023 0 - - Common Stock
Abraham Israeli None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Apr 2011 166,666 166,666 - - Stock Option (right to buy)
Robert G.L. Shorr None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2010 200,000 300,000 - - Common Stock
Malcolm S. Taub None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2010 100,000 100,000 - - Common Stock
Malcolm S. Taub None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2010 108,333 208,333 - - Common Stock
Malcolm S. Taub None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2010 130,000 338,333 - - Common Stock
Malcolm S. Taub None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 May 2010 100,000 238,333 - - Common Stock
Abraham Israeli None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Apr 2010 166,666 166,666 - - Stock Option (right to buy)
David Stolick Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Feb 2010 100,000 150,000 - - Common Stock
David Stolick Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Feb 2010 400,000 0 - - Stock Option (right to buy)
David Stolick Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Feb 2010 5,000 395,000 - - Common Stock
David Stolick Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Feb 2010 3,000 392,000 - - Common Stock
David Stolick Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Feb 2010 140,000 252,000 - - Common Stock
David Stolick Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Feb 2010 2,000 250,000 - - Common Stock
Jonathan C. Javitt None 31 Dec 2009 960,000 960,000 - - Common Stock
Jonathan C. Javitt None 31 Dec 2009 213,988 746,012 - - Common Stock
Jonathan C. Javitt None 31 Dec 2009 50,000 696,012 - - Common Stock
Jonathan C. Javitt None 31 Dec 2009 2,800 693,212 - - Common Stock
Jonathan C. Javitt None 31 Dec 2009 5,224 687,988 - - Common Stock
Jonathan C. Javitt None 31 Dec 2009 87,509 600,479 - - Common Stock
Jonathan C. Javitt None 31 Dec 2009 48,869 551,610 - - Common Stock
Jonathan C. Javitt None 31 Dec 2009 60,000 491,610 - - Common Stock
Jonathan C. Javitt None 31 Dec 2009 31,610 460,000 - - Common Stock
Irit Arbel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2009 100,000 100,000 - - Stock Option (right to buy)
Robert G.L. Shorr None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Oct 2009 5,000 295,000 - - Common Stock
Robert G.L. Shorr None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Oct 2009 50,000 245,000 - - Common Stock
Robert G.L. Shorr None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Oct 2009 50,000 195,000 - - Common Stock
Robert G.L. Shorr None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Oct 2009 25,000 170,000 - - Common Stock
Robert G.L. Shorr None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Oct 2009 10,000 140,000 - - Common Stock
Robert G.L. Shorr None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Oct 2009 20,000 140,000 - - Common Stock
Robert G.L. Shorr None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Oct 2009 40,000 100,000 - - Common Stock
Malcolm S. Taub None Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Sep 2009 350,000 900,000 - - Common Stock
Malcolm S. Taub None Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Sep 2009 225,000 675,000 - - Common Stock
Irit Arbel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2009 100,000 100,000 - - Stock Option (right to buy)
Moshe Lion None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2009 100,000 100,000 - - Stock Option (right to buy)
David Stolick Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2009 200,000 200,000 - - Stock Option (right to buy)
Abraham (Rami) Efrati Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2009 1,000,000 1,000,000 - - Stock Option (right to buy)
Malcolm S. Taub None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2009 100,000 100,000 - - Stock Option (right to buy)
Robert G.L. Shorr None Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 24 Oct 2007 100,000 300,000 - - Common Stock
Irit Arbel None Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 23 Oct 2007 100,000 0 - - Stock Option (right to buy)
Michael Greenfield (Ben-Ari) Other Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 23 Oct 2007 100,000 300,000 - - Common Stock
Abraham (Rami) Efrati Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Oct 2007 1,000,000 1,000,000 - - Stock Option (right to buy)
Jonathan C. Javitt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2007 100,000 100,000 - - Stock Option (right to buy)
Moshe Lion None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jul 2007 100,000 100,000 - - Stock Option (right to buy)
Robert G.L. Shorr None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2007 100,000 400,000 - - Common Stock
Irit Arbel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2007 100,000 100,000 - - Stock Option (right to buy)
Michael Greenfield (Ben-Ari) None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2007 100,000 400,000 - - Common Stock
Robert G.L. Shorr None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2007 100,000 300,000 - - Common Stock
Irit Arbel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2007 100,000 100,000 - - Stock Option (right to buy)
Yoram Drucker Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2007 250,000 250,000 - - Stock Option (right to buy)
Michael Greenfield (Ben-Ari) None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2007 100,000 300,000 - - Common Stock
David Stolick Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2007 350,000 350,000 - - Stock Option (right to buy)
Irit Arbel None Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Sep 2006 100,000 0 - - Stock Option (right to buy)
Irit Arbel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Sep 2006 100,000 100,000 - - Stock Option (right to buy)
Robert G.L. Shorr None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2006 100,000 200,000 - - Common Stock
Irit Arbel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2006 100,000 100,000 - - Stock Option (right to buy)
Yoram Drucker Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2006 100,000 100,000 - - Stock Option (right to buy)
Michael Greenfield (Ben-Ari) None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2006 100,000 200,000 - - Common Stock
David Stolick Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2006 100,000 100,000 - - Stock Option (right to buy)
David Stolick Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 06 Feb 2006 400,000 0 - - Stock Option (right to buy)
David Stolick Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2006 400,000 400,000 - - Stock Option (right to buy)
Robert G.L. Shorr None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 May 2005 100,000 100,000 - - Common Stock
Irit Arbel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 May 2005 100,000 100,000 - - Stock option (right to buy)
Michael Greenfield (Ben-Ari) None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 May 2005 100,000 100,000 - - COMMON STOCK
David Stolick Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2005 400,000 400,000 - - Stock Option (right to buy)
Yaffa Beck Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2004 1,828,692 1,828,692 - - Stock Option (right to buy)
Yoram Drucker Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2004 685,760 685,760 - - Stock Option (Right to Buy)
Frankenberger Mike Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2004 100,000 7,000,000 - - Common Stock
Frankenberger Mike Director, Ten Percent Owner Sale or transfer of securities back to the company at price $ 0.00 per share. 20 May 2004 6,880,000 120,000 - - Common Stock
Frankenberger Mike Other Other type of transaction at price $ 0.00 per share. 05 Dec 2003 8,500,000 8,462,000 - - Common Stock .00005 Par Value
Frankenberger Mike Other Other type of transaction at price $ 0.00 per share. 05 Dec 2003 1,562,000 6,900,000 - - Common Stock .00005 Par Value
Frankenberger Mike Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Dec 2003 100,000 7,000,000 - - Common Stock .00005 Par Value
Frankenberger Mike Other Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Dec 2003 6,880,000 120,000 - - Common Stock .00005 Par Value
Frankenberger Mike Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Dec 2003 20,000 140,000 - - Common Stock .00005 Par Value
Frankenberger Mike Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Dec 2003 15,000 155,000 - - Common Stock .00005 Par Value
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters